Bile duct cancer, Biliary tree cancers, Bladder cancer, Cervical cancer, Gallbladder cancer, Ovarian cancer, Pancreatic cancer, Secondary cancers, Womb (uterine or endometrial) cancer
Results
Phase 2
This trial was looking at trastuzumab deruxtecan for cancers that had a high number of receptors.
The trial was open for people to join between 2020 and 2022. The team published some results in 2023.
Recruitment start: 7 October 2020
Recruitment end: 7 July 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Banerjee
AstraZeneca
Last reviewed: 13 December 2024
CRUK internal database number: 17726
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
